Cubist Systematic Strategies, LLC Bio Rad Laboratories, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $19.3 Billion
  • Q3 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 2,983 shares of BIO stock, worth $934,126. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,983
Previous 1,000 198.3%
Holding current value
$934,126
Previous $241,000 246.89%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$241.95 - $303.82 $721,736 - $906,295
2,983 New
2,983 $836,000
Q1 2024

May 15, 2024
SELL
$304.11 - $351.99 $6.17 Million - $7.14 Million
-20,284 Reduced 99.36%
130 $44,000
Q4 2023

Feb 14, 2024
BUY
$269.37 - $365.04 $4.99 Million - $6.77 Million
18,543 Added 991.07%
20,414 $6.59 Million
Q3 2023

Nov 14, 2023
SELL
$350.25 - $422.63 $941,121 - $1.14 Million
-2,687 Reduced 58.95%
1,871 $670,000
Q2 2023

Aug 14, 2023
SELL
$359.49 - $486.4 $4.54 Million - $6.14 Million
-12,617 Reduced 73.46%
4,558 $1.73 Million
Q1 2023

May 15, 2023
SELL
$418.69 - $503.0 $145,285 - $174,541
-347 Reduced 1.98%
17,175 $8.23 Million
Q4 2022

Feb 14, 2023
SELL
$351.71 - $456.01 $1.44 Million - $1.87 Million
-4,098 Reduced 18.95%
17,522 $7.37 Million
Q3 2022

Nov 14, 2022
BUY
$412.59 - $563.26 $3.97 Million - $5.43 Million
9,633 Added 80.36%
21,620 $9.02 Million
Q2 2022

Aug 15, 2022
SELL
$463.67 - $597.16 $6.09 Million - $7.84 Million
-13,131 Reduced 52.28%
11,987 $5.93 Million
Q1 2022

May 16, 2022
BUY
$524.57 - $735.42 $6.63 Million - $9.3 Million
12,647 Added 101.41%
25,118 $14.1 Million
Q4 2021

Feb 14, 2022
BUY
$708.84 - $794.68 $4.36 Million - $4.89 Million
6,153 Added 97.39%
12,471 $9.42 Million
Q3 2021

Nov 15, 2021
BUY
$657.71 - $825.77 $1.06 Million - $1.33 Million
1,610 Added 34.2%
6,318 $4.71 Million
Q2 2021

Aug 16, 2021
SELL
$576.64 - $649.04 $3.94 Million - $4.43 Million
-6,826 Reduced 59.18%
4,708 $3.03 Million
Q1 2021

May 17, 2021
BUY
$547.01 - $662.35 $3.34 Million - $4.04 Million
6,105 Added 112.45%
11,534 $6.59 Million
Q4 2020

Feb 16, 2021
BUY
$510.68 - $643.45 $1.5 Million - $1.88 Million
2,929 Added 117.16%
5,429 $3.17 Million
Q3 2020

Nov 16, 2020
SELL
$454.43 - $535.6 $3.52 Million - $4.15 Million
-7,755 Reduced 75.62%
2,500 $1.29 Million
Q2 2020

Aug 14, 2020
BUY
$334.87 - $493.06 $485,896 - $715,430
1,451 Added 16.48%
10,255 $4.63 Million
Q1 2020

May 15, 2020
BUY
$320.01 - $409.07 $2.1 Million - $2.68 Million
6,552 Added 290.94%
8,804 $3.09 Million
Q4 2019

Feb 14, 2020
SELL
$319.73 - $374.2 $1.89 Million - $2.22 Million
-5,921 Reduced 72.45%
2,252 $833,000
Q3 2019

Nov 14, 2019
SELL
$304.55 - $345.24 $2.26 Million - $2.57 Million
-7,433 Reduced 47.63%
8,173 $2.72 Million
Q2 2019

Aug 14, 2019
BUY
$286.93 - $312.59 $3.14 Million - $3.42 Million
10,947 Added 234.96%
15,606 $4.88 Million
Q1 2019

May 15, 2019
BUY
$224.3 - $317.41 $572,862 - $810,665
2,554 Added 121.33%
4,659 $1.42 Million
Q4 2018

Feb 14, 2019
BUY
$220.1 - $309.0 $419,290 - $588,645
1,905 Added 952.5%
2,105 $489,000
Q3 2018

Nov 14, 2018
SELL
$289.28 - $326.15 $115,711 - $130,459
-400 Reduced 66.67%
200 $63,000
Q2 2018

Aug 14, 2018
BUY
$244.1 - $303.88 $32,465 - $40,416
133 Added 28.48%
600 $173,000
Q1 2018

May 15, 2018
SELL
$233.97 - $274.11 $1.16 Million - $1.36 Million
-4,945 Reduced 91.37%
467 $117,000
Q4 2017

Feb 14, 2018
BUY
$216.94 - $271.3 $563,393 - $704,566
2,597 Added 92.26%
5,412 $1.29 Million
Q3 2017

Nov 14, 2017
BUY
$212.27 - $242.28 $597,540 - $682,018
2,815
2,815 $626,000

Others Institutions Holding BIO

# of Institutions
438
Shares Held
19.4M
Call Options Held
6K
Put Options Held
3.3K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.71B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email